CME Group Inc. (NASDAQ:CME) Stock Has Consensus Price Target of $314.44 According to Analysts

CME Group logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts have a consensus “Hold” rating on CME Group, with 10 buy, 6 hold, and 2 sell recommendations among 18 firms. Their average 12-month price target is $314.44.
  • CME Group reported quarterly EPS of $3.02, beating estimates of $2.99, and revenue of $1.74 billion, above expectations; revenue rose 10.6% year over year.
  • The company declared a quarterly dividend of $1.30 per share, equivalent to an annualized yield of 1.7%. Insiders sold 61,166 shares worth about $18.3 million over the past 90 days.
  • MarketBeat previews the top five stocks to own by December 1st.

Shares of CME Group Inc. (NASDAQ:CME - Get Free Report) have received an average recommendation of "Hold" from the eighteen ratings firms that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $314.44.

CME has been the subject of several recent research reports. Barclays increased their price target on CME Group from $281.00 to $321.00 and gave the company an "equal weight" rating in a research note on Thursday, October 22nd. Wells Fargo & Company increased their price target on shares of CME Group from $315.00 to $333.00 and gave the stock an "overweight" rating in a report on Thursday, October 22nd. TD Cowen boosted their price objective on CME Group from $292.00 to $300.00 and gave the company a "buy" rating in a research report on Monday, October 5th. Weiss Ratings upgraded shares of CME Group from a "buy (b)" rating to a "buy (b+)" rating in a report on Friday, November 13th. Finally, JPMorgan Chase & Co. raised shares of CME Group from an "underweight" rating to an "overweight" rating and set a $367.00 price objective for the company in a report on Thursday, October 22nd.

View Our Latest Analysis on CME Group

CME Group Stock Down 1.3%

CME stock opened at $306.31 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group has a 1 year low of $218.31 and a 1 year high of $329.16. The company has a fifty day simple moving average of $288.79 and a 200 day simple moving average of $282.00. The firm has a market cap of $109.64 billion, a PE ratio of 25.13, a PEG ratio of 3.79 and a beta of 0.15.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.99 by $0.03. The business had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. CME Group's quarterly revenue was up 10.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.68 EPS. Sell-side analysts anticipate that CME Group will post 12.35 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 11th will be issued a dividend of $1.30 per share. The ex-dividend date is Friday, December 11th. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. CME Group's dividend payout ratio (DPR) is presently 42.66%.

Insiders Place Their Bets

In other CME Group news, Director Howard J. Siegel sold 2,000 shares of the company's stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $303.00, for a total value of $606,000.00. Following the sale, the director owned 19,873 shares in the company, valued at approximately $6,021,519. This represents a 9.14% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Terrence A. Duffy sold 27,000 shares of the stock in a transaction that occurred on Wednesday, November 18th. The shares were sold at an average price of $309.57, for a total value of $8,358,390.00. Following the transaction, the chief executive officer owned 35,442 shares in the company, valued at $10,971,779.94. This trade represents a 43.24% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 61,166 shares of company stock worth $18,276,512. Insiders own 0.30% of the company's stock.

Institutional Investors Weigh In On CME Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CME. BlackRock Inc. acquired a new stake in CME Group during the 2nd quarter worth $6,749,965,000. Bank of New York Mellon Corp acquired a new stake in shares of CME Group in the second quarter valued at approximately $867,313,000. Alphabet Inc. purchased a new stake in CME Group in the 2nd quarter valued at about $769,376,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in CME Group during the second quarter valued at about $629,771,000. Finally, Bank of America Corp DE purchased a new position in CME Group in the second quarter valued at about $622,679,000. Hedge funds and other institutional investors own 87.75% of the company's stock.

Trending Headlines about CME Group

Investors following CME have been watching these headlines:

  • Neutral Sentiment: CEO Terrence Duffy discussed CME Group’s Tour Championship and prediction markets in a media interview, but the coverage provided no specific financial or business update. Article
  • Negative Sentiment: Duffy sold 27,000 shares for about $8.36 million, reducing his direct stake by 43.24%. General Counsel John Clifford Marchese also sold 655 shares, an 18.20% reduction in his holdings. Insider sales can be made for personal reasons and do not necessarily signal a change in company outlook, but the CEO’s sale may weigh on sentiment. CEO filing General counsel filing
  • Negative Sentiment: A valuation-focused report says CME shares may be fully valued after a 69% run, raising the risk that expectations are already reflected in the price. Article

CME Group Company Profile

(Get Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

See Also

Analyst Recommendations for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines